“Managing Your Tissue for Cancer Analysis” (Bernardo Cordovez) [#198]

Brad Power

June 17, 2026

“Tissue is arguably your most important asset in guiding your care. I think the pathologists here in the audience would argue positively for that. It's the first step in diagnosis, and that information is then later relayed to an oncologist to pursue and approve therapy.” – Bernardo Cordovez, PhD

“I just started doing this six months ago. The response has been extraordinary. We were founded because somebody, a billionaire, struggled to collect his tissues on three different occasions. It's a problem that everybody has.” – Bernardo Cordovez, PhD

“Personalized oncology is not here today. We're trying, with everybody else here, to bring it into the present. Patients have a ton of say in what happens with their tissue, and their tissue has a ton of unlocked potential energy to determine what the best things for them to do in an advanced care journey.” – Bernardo Cordovez, PhD

Abstract

Managing tumor tissue after a biopsy is a critical, often overlooked step that allows cancer patients and caregivers to unlock personalized treatment options through live tissue banking, which preserves active cells for direct drug testing rather than destroying them with standard chemicals. By navigating hospital logistics and advocating for specialized tissue handling, patients can secure a live-cell blueprint to determine the most effective therapy for their specific cancer.

Meeting Summary

Managing your tumor tissue after a biopsy is one of the most powerful yet overlooked parts of modern cancer care. Your tissue is not just medical waste; it is a vital blueprint of your specific disease. When a cancer biopsy is performed, your tissue is usually treated with chemicals that preserve the tissue, but kill the cells, which can unintentionally lock you out of groundbreaking personalized treatments. Cancer patients and caregivers can take control of their tissue by opting for live tissue banking, a process that preserves active cancer cells so doctors can test drugs directly on your specific tumor before you ever take them. Understanding the challenges and opportunities of tissue management allows you to take active control of your treatment. You need to learn how to navigate hospital logistics, ask your surgical team the right questions, and unlock advanced, live-cell testing options that offer a clearer blueprint for your recovery.

Bernardo Cordovez, PhD, is uniquely qualified to lead a conversation on tissue management because he bridges the gap between complex biotechnology and real-world patient advocacy. His distinct combination of deep technical expertise and entrepreneurial success allows him to demystify pathology logistics for families navigating a diagnosis. He is a Cornell-trained biotechnology expert and founder of Kernis Health. He specializes in helping families intercept standard hospital protocols to preserve active, living tumor tissue for personalized drug testing.

Why do you need to know about tissue management in your cancer care?

  • Find personalized treatments: Tumor tissue is the foundation for finding personalized treatments (functional testing, cancer vaccines, organoids), so how it is saved dictates your future testing options.

  • Avoid standard process trap: Standard hospital workflows default to "FFPE" (chemical fixing), which permanently destroys live cells and ruins the delicate molecules needed for advanced testing.

  • Access personalized options: Insisting that a portion of your tissue be saved "live" or "flash-frozen" allows you to access cutting-edge therapies like cancer vaccines, tumor organoids, and functional drug testing.

  • Control: You should direct allocation of your tissue so it can be used where it helps you most, avoiding reliance on institutional workflows and control, which can result in loss of material for tests you choose.

What are limitations on actively engaging in tissue management in your cancer care?

  • Hospitals lack workflows: Most medical centers do not have an automated process for patient-directed fresh tissue requests, meaning you will face significant administrative friction and resistance.

  • Severe time constraints: Live tissue requires immediate, expert handling; missing the ultra-short timeline to flash-freeze or submerge it in special live media permanently ruins the sample.

  • High out-of-pocket costs: Transitioning away from a hospital's default path is expensive, logistically complex, and private biobanking services frequently start around $5,000 without insurance coverage.

  • Standard testing is still vital: Not every advanced cancer test requires fresh tissue, and standard chemical preservation (FFPE) is still perfectly adequate for many highly effective, traditional diagnostics.

  • Exhausting brute-force advocacy: Until hospital systems adapt to personalized oncology demands, successfully saving live tissue requires aggressive, proactive management by the patient or a dedicated caregiver.

How should you coordinate live tissue banking before a scheduled surgery?

  • Lock in your team early: Confirm your surgeon is willing to cooperate, sign all required patient consent forms, and create a strict "tissue roadmap" that balances the hospital's diagnostic needs with your private banking goals.

  • Ship kits and secure vendors: Order specialized live-media transport kits or cryopreservation containers well ahead of time, hire a certified medical courier, and verify total out-of-pocket costs (typically starting above $5,000).

  • Deploy a day-of coordinator: Have a trusted friend, advocate, or company representative physically present at the hospital to manage logistics, minimize the time tissue sits out, and hand the fresh sample directly to the courier.

  • Enforce strict timing rules: Work directly with the hospital’s internal biorepository team to smoothly inject your plan into the operating room workflow, ensuring the tissue is submerged or frozen before it degrades.

  • Secure the chain of custody: Immediately document the sample's condition, track its location from the operating room to the destination lab, and confirm you retain legal rights to retrieve the remaining standard tissue blocks if needed.

What can you do to manage your tissue in your cancer care?

  • Demand a formal tissue roadmap: Sit down with your surgeon before the procedure to create a written allocation plan that guarantees the hospital gets its diagnostic samples first, while reserving a fresh portion for you.

  • Hire a private patient-directed biobank: Partner with an independent custodial service to secure legal ownership of your tissue, ensuring it is stored safely and can be shipped to any advanced testing lab in the future. 

  • Match preservation to your target therapies: Instruct the team to flash-freeze samples for future cancer vaccines and advanced DNA/RNA sequencing, or use specialized live-media transport kits for functional drug testing and growing tumor organoids.

  • Enforce an ultra-fast freezing timeline: Mandate that the surgical team minimize the time tissue sits out at room temperature, arranging for immediate onsite flash-freezing or instant submersion into validated cold-chain shipping kits.

  • Prepare for emergency exceptions: If your upcoming surgery is urgent or unexpected, bypass long-term planning and immediately prioritize getting a standardized, live-transport kit directly into the operating room.

What questions should you ask your medical team about tissue management?

  • Who legally controls my tissue, and can I transfer ownership to a private biobank?

  • How much leftover tissue can be saved fresh before you chemically fix the rest?

  • Who is the specific person responsible for handing my fresh sample to the courier?

  • What is the exact timeline to ensure my tissue is frozen or stored before it dies?

How can you learn more about tissue management for your cancer care?


The information and opinions expressed on this website or platform, or during discussions and presentations (both verbal and written) are solely for educational purposes and are not intended as health care recommendations or medical advice by Cancer Patient Lab, its principals, presenters, participants, or representatives for any medical treatment, product, or course of action. You should always consult a doctor about your specific situation before pursuing any health care program, treatment, product or other course of action that might affect your health. This summary was prepared with the assistance of transcription and AI-assisted editing tools and was reviewed by Cancer Patient Lab staff.


For the video recording, please see here.

For the slides, please see here.

For a transcript of the conversation, please see here.